- Home
- KGEI vs DRTS Comparison
KGEI vs DRTS Comparison
Compare KGEI & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- DRTS
- Stock Information
- Founded
- KGEI 2008
- DRTS 2015
- Country
- KGEI United States
- DRTS Israel
- Employees
- KGEI N/A
- DRTS N/A
- Industry
- KGEI
- DRTS Medical/Dental Instruments
- Sector
- KGEI
- DRTS Health Care
- Exchange
- KGEI Nasdaq
- DRTS Nasdaq
- Market Cap
- KGEI 262.6M
- DRTS 211.7M
- IPO Year
- KGEI N/A
- DRTS N/A
- Fundamental
- Price
- KGEI $8.91
- DRTS $2.45
- Analyst Decision
- KGEI Strong Buy
- DRTS Strong Buy
- Analyst Count
- KGEI 1
- DRTS 2
- Target Price
- KGEI $11.00
- DRTS $8.00
- AVG Volume (30 Days)
- KGEI 126.3K
- DRTS 33.4K
- Earning Date
- KGEI 03-25-2025
- DRTS 03-12-2025
- Dividend Yield
- KGEI N/A
- DRTS N/A
- EPS Growth
- KGEI N/A
- DRTS N/A
- EPS
- KGEI 0.50
- DRTS N/A
- Revenue
- KGEI $58,651,000.00
- DRTS N/A
- Revenue This Year
- KGEI $39.41
- DRTS N/A
- Revenue Next Year
- KGEI $24.46
- DRTS N/A
- P/E Ratio
- KGEI $17.70
- DRTS N/A
- Revenue Growth
- KGEI 15.91
- DRTS N/A
- 52 Week Low
- KGEI $2.85
- DRTS $1.75
- 52 Week High
- KGEI $9.89
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- KGEI 56.36
- DRTS 33.37
- Support Level
- KGEI $6.57
- DRTS $2.60
- Resistance Level
- KGEI $8.71
- DRTS $2.68
- Average True Range (ATR)
- KGEI 0.57
- DRTS 0.13
- MACD
- KGEI 0.08
- DRTS 0.00
- Stochastic Oscillator
- KGEI 78.97
- DRTS 0.00
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.